Journal of Parenteral and Enteral Nutrition

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dray, X.
Right arrow Articles by Marteau, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dray, X.
Right arrow Articles by Marteau, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Parenteral and Enteral Nutrition, Vol. 29, No. 4 suppl, S166-S172 (2005)
DOI: 10.1177/01486071050290S4S166
© 2005 The American Society for Parenteral and Enteral Nutrition

Presentations

The Use of Enteral Nutrition in the Management of Crohn's Disease in Adults

X. Dray, MD* and Phillipe Marteau, MD, PhD{dagger}

From the * Service d'Hépato-Gastroentérologie et Assistance Nutritive, Hôpital Lariboisière, Assistance Publique des Hôpitaux de Paris, France; and the {dagger} Service de Gastroentérologie, Hôpital Européen Georges Pompidou, Assistance Publique des Hôpitaux de Paris, France

Correspondence: Philippe Marteau, MD, PhD, Service d'hépato-gastroentérologie, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75908 Paris cedex 15, France. Electronic mail may be sent to philippe.marteau{at}egp.ap-hop-paris.fr.

Crohn's disease is a chronic, relapsing disease and none of the treatments developed so far can cure it. Artificial nutrition is effective to both treat malnutrition when present and induce remission. However, striking advances in anti-inflammatory and immunomodulating therapies (including infliximab) and low compliance to treatment in the first trials have limited its place in the management of adults to drug-resistant patients. Randomized controlled trials show that artificial nutrition is effective in >50% of the cases in this selected population. Significant progress has recently been made to improve the palatability (and thus acceptability) of some enteral solutions, which can be consumed by the oral route and as pharmaconutrition. We reviewed the literature on enteral nutrition in adults with Crohn's disease. We present herein the results of the studies performed with antioxidants, glutamine, short-chain fatty acids, prebiotics, probiotics, low microparticle diets, and a TGFβ2 enriched formulation.


 

Discussion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nutr Clin PractHome page
D. M. Wiese, R. Rivera, and D. L. Seidner
Is There a Role for Bowel Rest in Nutrition Management of Crohn's Disease?
Nutr Clin Pract, June 1, 2008; 23(3): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
P. S. Anthony
Foreword
JPEN J Parenter Enteral Nutr, July 1, 2005; 29(4_suppl): S107 - S107.
[Full Text] [PDF]